Clearmind Medicine INC F-1 registration statements

Clearmind Medicine Inc. files an amended F-1 registration statement to register 12,545,230 common shares for resale by selling shareholders, stemming from warrant adjustments and recent capital raises.

Clearmind Medicine Inc. filed an F-1 registration statement for the resale of up to 5,781,250 common shares by selling shareholders, stemming from warrant exercises and recent financing activities, while addressing Nasdaq listing compliance.

Clearmind Medicine Inc. filed an F-1 registration statement for the resale of up to 17 million common shares by selling shareholders, following a $9 million convertible note financing to fund ongoing psychedelic medicine clinical trials.

Clearmind Medicine Inc. has filed a registration statement for the resale of up to 1,500,000 common shares by selling shareholders, which are issuable upon the exercise of warrants originally issued in a private placement.